What is Perry Baromedical?
Perry Baromedical is a distinguished leader in the manufacturing, installation, and servicing of hyperbaric oxygen therapy (HBOT) systems. With over five decades of industry experience, the company offers a comprehensive suite of HBOT solutions, including monoplace, dualplace, and multiplace chambers, alongside essential accessories and equipment. Their expertise extends to facility design, preventative maintenance, and specialized training for medical professionals, catering to healthcare facilities and practitioners seeking advanced hyperbaric solutions.
How much funding has Perry Baromedical raised?
Perry Baromedical has raised a total of $520K across 2 funding rounds:
Debt
$150K
Debt
$370K
Debt (2020): $150K with participation from PPP
Debt (2021): $370K led by PPP
What's next for Perry Baromedical?
The recent major strategic investment positions Perry Baromedical for continued growth and innovation in the hyperbaric medicine market. This capital infusion is expected to fuel advancements in their product lines, enhance service capabilities, and potentially expand their market reach. As a company with a long-standing reputation, this backing signifies confidence in their business model and future prospects, likely enabling further development of their high-quality hyperbaric systems and supporting infrastructure.
See full Perry Baromedical company page
